Search
for
Sort by
Research 241–270 of 845
- Gender Differences in Production and Circulating Levels of Sex Hormones and Their Impact on Aging Skin
- Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto
- Effect of neurosteroid dehydroepiandrosterone on the higher nervous activity of old non-human primates
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Inhibition of Rat 5<i>α</i>-Reductase Activity and Testosterone-Induced Sebum Synthesis in Hamster Sebocytes by an Extract of<i>Quercus acutissima</i>Cortex
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Effect of the allopregnanolone and allotetrahydrodeoxycorticosteron on spike-wave discharges in the EEG of absence epilepsy rat models
- Test With Oral Administration of Clomiphene May Add to Differential Diagnosis of Severe Hyperandrogenism in Postmenopausal Women - A Case Report
- Effects of testosterone on mean arterial pressure and aquaporin (AQP)-1, 2, 3, 4, 6 and 7 expressions in the kidney of orchidectomized, adult male Sprague-Dawley rats
- Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
- Use of spironolactone in dermatology.
- Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment of Female Pattern Hair Loss: A Comparative, Clinical, and Trichoscopic Study
- Efficacy of oral spironolactone in the treatment of androgenetic alopecia in female patients: A case series of 11 patients
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis
- The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone
- Sub-chronic testosterone treatment increases the levels of epithelial sodium channel (ENaC)-<i>α</i>,<i>β</i>and<i>γ</i>in the kidney of orchidectomized adult male Sprague–Dawley rats
- Follicular-targeted delivery of spironolactone provided by polymeric nanoparticles
- Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats
- Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot study
- Liquid chromatography-mass spectrometry for simultaneous determination of spironolactone and canrenone in plasma samples
- Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar‐I disorder: A double‐blind, randomized, placebo‐controlled clinical trial
- The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- A Systematic Review of Spironolactone Nano-Formulations for Topical Treatment of Skin Hyperandrogenic Disorders and Chronic Wounds
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- 0932 Spatiotemporal gradient of mesenchymal stiffness controls sweat gland morphogenesis
- Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation
- Direct Vasodilators and Sympatholytic Agents